These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5161823)

  • 1. [Use of the hemostatic spongostan in otorhinolaryngologic practice].
    Revskoĭ IuK
    Zh Ushn Nos Gorl Bolezn; 1971; 31(4):98. PubMed ID: 5161823
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of otorhinolaryngologic hemorrhage].
    Werner U
    Z Arztl Fortbild (Jena); 1969 May; 63(9):493-6. PubMed ID: 5803095
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in the use of the local hemostatic agent Kaprofer in otorhinolaryngologic practice].
    Dunaĭvitser BI; Gulunian EA; Lalaev KV; Manukian VM
    Vestn Otorinolaringol; 1987; (5):71-3. PubMed ID: 3424525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical observations on the hemostatic action of ascorbo-chrome].
    Amorelli ; Pezzarossa G
    Arch Ital Laringol; 1968; 76(6):337-48. PubMed ID: 5309435
    [No Abstract]   [Full Text] [Related]  

  • 5. [141 MD (Dicynone) in ORL. New synthetic hemostatic and antihemorrhagic agent].
    Wayoff M; Jeannin A; Jeannin C
    Ann Otolaryngol Chir Cervicofac; 1966; 83(4):361-70. PubMed ID: 5935945
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methods of drainage and tamponment in otorhinolaryngologic practice].
    Gadzhimirzaev GA
    Vestn Otorinolaringol; 1998; (6):44-7. PubMed ID: 10081401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary clinical experience with a new hemostatic: dicyone].
    Del Prete S; Fruttero F
    Minerva Otorinolaringol; 1967; 17(3):73-5. PubMed ID: 5606754
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of hemorrhage in otorhinolaryngologic surgery with oxidized regenerated cellulose.
    Huggins S
    Eye Ear Nose Throat Mon; 1969 Jul; 48(7):420-3. PubMed ID: 5793775
    [No Abstract]   [Full Text] [Related]  

  • 9. [Application of dry lyophilized vicasal plasma for the prevention and therapy of hemorrhages in otolaryngological practice].
    Glantz RM; Genshenza ST
    Zh Ushn Nos Gorl Bolezn; 1967; 27(6):10-3. PubMed ID: 5622874
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemostatic action of estrogens in ORL. Trials of Premarine].
    Hadj-Djilani A
    Rev Med Suisse Romande; 1966 Mar; 86(3):216-24. PubMed ID: 4286236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemostatic effect of Emex in treatment of hemorrhage in otorhinolaryngology].
    Haci Boskov A; Glavas O; Georgievski P
    God Zb Med Fak Skopje; 1972; 18():381-6. PubMed ID: 4663219
    [No Abstract]   [Full Text] [Related]  

  • 12. [The hemostyptic agent Altodor in otorhinopharyngology].
    Broicher FJ
    Munch Med Wochenschr; 1967 Oct; 109(43):2235-8. PubMed ID: 5631419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with the use of Oxycell (polyanhydroglucuronic acid) in the field of otorhinolaryngology].
    Yamaga Y; Kuga T
    Jibiinkoka; 1969 Jan; 41(1):53-6. PubMed ID: 5813783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical uses of the sulfonic ester of adrenochrome semicarbazone (EMEX) in otorhinolaryngoiatric practice].
    Russo C
    Ann Laringol Otol Rinol Faringol; 1966; 65(4):499-514. PubMed ID: 6014493
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of local freezing in hemorrhages from the ENT organs].
    Sel'din MN; Rudnia PG; Komarov BA; Livandovskiĭ IuA
    Zh Ushn Nos Gorl Bolezn; 1973; 33(2):85-6. PubMed ID: 4775709
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of O.R.L. hemorrhage in constitutional anomalies of hemostasis: apropos of several cases].
    Laharrague P; Ané P; Inchauspé M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Sep; 30(7):423-4, 427-31. PubMed ID: 6457121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of hemostatic gauze on a modified cellulose base in otorhinolaryngologic surgery].
    Khodakov IG; Penenzhik MA; Virnik AD
    Vestn Otorinolaringol; 1969; 31(1):74-6. PubMed ID: 5376678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemostatic effect of conjugated estrogenic substances].
    Toriyama M; Hoshino T; Sato Y
    Jibiinkoka; 1967 Mar; 39(3):333-6. PubMed ID: 4294843
    [No Abstract]   [Full Text] [Related]  

  • 19. Making sense of the preclinical literature on advanced hemostatic products.
    Valeri CR
    J Trauma; 2006 Jul; 61(1):240-1; author reply 241. PubMed ID: 16832287
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenetic principles in the therapy of hemostatic disorders].
    Baluda VP; Sushkevich GN; Pavlovskiĭ DP
    Patol Fiziol Eksp Ter; 1977; (5):56-8. PubMed ID: 600556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.